↓ Skip to main content

Intravenous secretin for autism spectrum disorders (ASD)

Overview of attention for article published in Cochrane database of systematic reviews, April 2012
Altmetric Badge

About this Attention Score

  • In the top 5% of all research outputs scored by Altmetric
  • High Attention Score compared to outputs of the same age (98th percentile)
  • High Attention Score compared to outputs of the same age and source (96th percentile)

Mentioned by

news
1 news outlet
blogs
5 blogs
twitter
3 tweeters
patent
23 patents
facebook
1 Facebook page

Citations

dimensions_citation
32 Dimensions

Readers on

mendeley
101 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Intravenous secretin for autism spectrum disorders (ASD)
Published in
Cochrane database of systematic reviews, April 2012
DOI 10.1002/14651858.cd003495.pub3
Pubmed ID
Authors

Katrina Williams, John A Wray, Danielle M Wheeler

Abstract

In 1998 secretin, a gastrointestinal hormone, was suggested as an effective treatment for autism spectrum disorders (ASD) based on anecdotal evidence.

Twitter Demographics

The data shown below were collected from the profiles of 3 tweeters who shared this research output. Click here to find out more about how the information was compiled.

Mendeley readers

The data shown below were compiled from readership statistics for 101 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
South Africa 1 <1%
Unknown 100 99%

Demographic breakdown

Readers by professional status Count As %
Student > Ph. D. Student 4 4%
Researcher 3 3%
Student > Bachelor 2 2%
Student > Master 2 2%
Student > Postgraduate 1 <1%
Other 0 0%
Unknown 89 88%
Readers by discipline Count As %
Psychology 5 5%
Medicine and Dentistry 3 3%
Nursing and Health Professions 2 2%
Neuroscience 1 <1%
Social Sciences 1 <1%
Other 0 0%
Unknown 89 88%

Attention Score in Context

This research output has an Altmetric Attention Score of 49. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 03 April 2018.
All research outputs
#315,293
of 12,745,229 outputs
Outputs from Cochrane database of systematic reviews
#928
of 10,420 outputs
Outputs of similar age
#2,138
of 119,306 outputs
Outputs of similar age from Cochrane database of systematic reviews
#4
of 102 outputs
Altmetric has tracked 12,745,229 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 97th percentile: it's in the top 5% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 10,420 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 20.3. This one has done particularly well, scoring higher than 91% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 119,306 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 98% of its contemporaries.
We're also able to compare this research output to 102 others from the same source and published within six weeks on either side of this one. This one has done particularly well, scoring higher than 96% of its contemporaries.